A task force of allergists and immunologists recommends those administering the COVID-19 vaccine ask patients some key questions beforehand. While reactions to vaccines are extremely rare, the American College of Allergy, Asthma and Immunology (ACAAI) said anyone being vaccinated should be asked if they have a history of a severe allergic reaction to an injectable medication. If the answer is yes, the individual should be referred to a board-certified allergist for evaluation before getting the COVID-19 vaccination, ACAAI said in a news release. The academy also said COVID-19 vaccines should be given in a health care facility where an allergic reaction can be treated. Patients must be monitored for at least 15 to 30 minutes after injection for any adverse reaction. COVID-19 vaccines should not be given to people with a known history of severe allergic reaction to any component of the vaccine. According to the U.S. Centers for Disease Control and Prevention, if you have a severe allergic reaction after the first shot, you should not get the second shot. Data regarding risk in individuals with a history of allergic reactions is very limited and evolving, according to ACAAI. Patients and doctors should balance the risks and benefits of vaccination. People with allergies to medications, foods, inhalants, insects and latex are probably no more likely than others to have an allergic reaction to COVID-19…  read on >  read on >

President-elect Joe Biden plans to release nearly all available doses of COVID-19 vaccine when he takes office, reversing the Trump administration’s strategy of holding back half the supply to ensure second doses are available. The potentially risky move is meant to boost a nationwide COVID-19 vaccination program that has gotten off to a slow start, with only about 5.9 million doses administered out of 29.4 million distributed, according to the U.S. Centers for Disease Control and Prevention. “The President-elect believes we must accelerate distribution of the vaccine while continuing to ensure the Americans who need it most get it as soon as possible,” T.J. Ducklo, a spokesperson for Biden’s transition, told CNN. Biden “will share additional details next week on how his administration will begin releasing available doses when he assumes office on January 20th,” Ducklo added. One infectious diseases expert noted that supply is not the only issue hampering the vaccine rollout. “I do think it is important to get all of those out as fast as possible so we can accelerate the process of vaccination,” said Dr. Amesh Adalja, a senior scholar at Johns Hopkins Center for Health Security, in Baltimore. “However, it’s not just an issue of doses, it’s about turning those doses into actual vaccinations, so we do still need more support at the state level to actually implement vaccination programs.…  read on >  read on >

A task force of allergists and immunologists recommends those administering the COVID-19 vaccine ask patients some key questions beforehand. While reactions to vaccines are extremely rare, the American College of Allergy, Asthma and Immunology (ACAAI) said anyone being vaccinated should be asked if they have a history of a severe allergic reaction to an injectable medication. If the answer is yes, the individual should be referred to a board-certified allergist for evaluation before getting the COVID-19 vaccination, ACAAI said in a news release. The academy also said COVID-19 vaccines should be given in a health care facility where an allergic reaction can be treated. Patients must be monitored for at least 15 to 30 minutes after injection for any adverse reaction. COVID-19 vaccines should not be given to people with a known history of severe allergic reaction to any component of the vaccine. According to the U.S. Centers for Disease Control and Prevention, if you have a severe allergic reaction after the first shot, you should not get the second shot. Data regarding risk in individuals with a history of allergic reactions is very limited and evolving, according to ACAAI. Patients and doctors should balance the risks and benefits of vaccination. People with allergies to medications, foods, inhalants, insects and latex are probably no more likely than others to have an allergic reaction to COVID-19…  read on >  read on >

President-elect Joe Biden plans to release nearly all available doses of COVID-19 vaccine when he takes office, reversing the Trump administration’s strategy of holding back half the supply to ensure second doses are available. The potentially risky move is meant to boost a nationwide COVID-19 vaccination program that has gotten off to a slow start, with only about 5.9 million doses administered out of 29.4 million distributed, according to the U.S. Centers for Disease Control and Prevention. “The President-elect believes we must accelerate distribution of the vaccine while continuing to ensure the Americans who need it most get it as soon as possible,” T.J. Ducklo, a spokesperson for Biden’s transition, told CNN. Biden “will share additional details next week on how his administration will begin releasing available doses when he assumes office on January 20th,” Ducklo added. One infectious diseases expert noted that supply is not the only issue hampering the vaccine rollout. “I do think it is important to get all of those out as fast as possible so we can accelerate the process of vaccination,” said Dr. Amesh Adalja, a senior scholar at Johns Hopkins Center for Health Security, in Baltimore. “However, it’s not just an issue of doses, it’s about turning those doses into actual vaccinations, so we do still need more support at the state level to actually implement vaccination programs.…  read on >  read on >

A task force of allergists and immunologists recommends those administering the COVID-19 vaccine ask patients some key questions beforehand. While reactions to vaccines are extremely rare, the American College of Allergy, Asthma and Immunology (ACAAI) said anyone being vaccinated should be asked if they have a history of a severe allergic reaction to an injectable medication. If the answer is yes, the individual should be referred to a board-certified allergist for evaluation before getting the COVID-19 vaccination, ACAAI said in a news release. The academy also said COVID-19 vaccines should be given in a health care facility where an allergic reaction can be treated. Patients must be monitored for at least 15 to 30 minutes after injection for any adverse reaction. COVID-19 vaccines should not be given to people with a known history of severe allergic reaction to any component of the vaccine. According to the U.S. Centers for Disease Control and Prevention, if you have a severe allergic reaction after the first shot, you should not get the second shot. Data regarding risk in individuals with a history of allergic reactions is very limited and evolving, according to ACAAI. Patients and doctors should balance the risks and benefits of vaccination. People with allergies to medications, foods, inhalants, insects and latex are probably no more likely than others to have an allergic reaction to COVID-19…  read on >  read on >

A task force of allergists and immunologists recommends those administering the COVID-19 vaccine ask patients some key questions beforehand. While reactions to vaccines are extremely rare, the American College of Allergy, Asthma and Immunology (ACAAI) said anyone being vaccinated should be asked if they have a history of a severe allergic reaction to an injectable medication. If the answer is yes, the individual should be referred to a board-certified allergist for evaluation before getting the COVID-19 vaccination, ACAAI said in a news release. The academy also said COVID-19 vaccines should be given in a health care facility where an allergic reaction can be treated. Patients must be monitored for at least 15 to 30 minutes after injection for any adverse reaction. COVID-19 vaccines should not be given to people with a known history of severe allergic reaction to any component of the vaccine. According to the U.S. Centers for Disease Control and Prevention, if you have a severe allergic reaction after the first shot, you should not get the second shot. Data regarding risk in individuals with a history of allergic reactions is very limited and evolving, according to ACAAI. Patients and doctors should balance the risks and benefits of vaccination. People with allergies to medications, foods, inhalants, insects and latex are probably no more likely than others to have an allergic reaction to COVID-19…  read on >  read on >

President-elect Joe Biden plans to release nearly all available doses of COVID-19 vaccine when he takes office, reversing the Trump administration’s strategy of holding back half the supply to ensure second doses are available. The potentially risky move is meant to boost a nationwide COVID-19 vaccination program that has gotten off to a slow start, with only about 5.9 million doses administered out of 29.4 million distributed, according to the U.S. Centers for Disease Control and Prevention. “The President-elect believes we must accelerate distribution of the vaccine while continuing to ensure the Americans who need it most get it as soon as possible,” T.J. Ducklo, a spokesperson for Biden’s transition, told CNN. Biden “will share additional details next week on how his administration will begin releasing available doses when he assumes office on January 20th,” Ducklo added. One infectious diseases expert noted that supply is not the only issue hampering the vaccine rollout. “I do think it is important to get all of those out as fast as possible so we can accelerate the process of vaccination,” said Dr. Amesh Adalja, a senior scholar at Johns Hopkins Center for Health Security, in Baltimore. “However, it’s not just an issue of doses, it’s about turning those doses into actual vaccinations, so we do still need more support at the state level to actually implement vaccination programs.…  read on >  read on >

President-elect Joe Biden plans to release nearly all available doses of COVID-19 vaccine when he takes office, reversing the Trump administration’s strategy of holding back half the supply to ensure second doses are available. The potentially risky move is meant to boost a nationwide COVID-19 vaccination program that has gotten off to a slow start, with only about 5.9 million doses administered out of 29.4 million distributed, according to the U.S. Centers for Disease Control and Prevention. “The President-elect believes we must accelerate distribution of the vaccine while continuing to ensure the Americans who need it most get it as soon as possible,” T.J. Ducklo, a spokesperson for Biden’s transition, told CNN. Biden “will share additional details next week on how his administration will begin releasing available doses when he assumes office on January 20th,” Ducklo added. One infectious diseases expert noted that supply is not the only issue hampering the vaccine rollout. “I do think it is important to get all of those out as fast as possible so we can accelerate the process of vaccination,” said Dr. Amesh Adalja, a senior scholar at Johns Hopkins Center for Health Security, in Baltimore. “However, it’s not just an issue of doses, it’s about turning those doses into actual vaccinations, so we do still need more support at the state level to actually implement vaccination programs.…  read on >  read on >